New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases and resulting in prolonged illness, disability and death. That is to say, without effective antimicrobials for prevention and treatment of infections, medical procedures such as organ transplantation, cancer chemotherapy,
diabetes management and major surgery (for example, caesarean sections or hip replacements) become very high-risk.
In fact, every single year, 25,000 Europeans are dying because of antimicrobial resistance; And without direct action on a massive scale, things will only get worse.
In Luxembourg, there was a company who shared their vision for a healthier world.
This company was the Probiotic Group. With a team of industry-leading scientists, they use the power of helpful bacteria called probiotics to develop a comprehensive and adaptive range of care and cleaning products that create a healthy and balanced microscopic environment or microbiome.
As one of Europe’s leading experts in their field, Probiotic Group are at the forefront of the battle against the ever-evolving dangers that resistant infections – and impairment of our natural eco-system – pose to human and animal health.
Their partnership is testimony to our joint belief that people, animals and the environment can enjoy a better quality of life.